HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,296,000 | +40.8% | 59,100 | 0.0% | 0.08% | +37.9% |
| Q1 2018 | $1,631,000 | +52.4% | 59,100 | 0.0% | 0.06% | +75.8% |
| Q4 2017 | $1,070,000 | +12.2% | 59,100 | 0.0% | 0.03% | -17.5% |
| Q3 2017 | $954,000 | +16.5% | 59,100 | 0.0% | 0.04% | +233.3% |
| Q2 2017 | $819,000 | -7.7% | 59,100 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $887,000 | +14.6% | 59,100 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $774,000 | -24.0% | 59,100 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $1,018,000 | -52.3% | 59,100 | -50.0% | 0.02% | -45.5% |
| Q2 2016 | $2,134,000 | +90.2% | 118,200 | +100.0% | 0.03% | +73.7% |
| Q1 2016 | $1,122,000 | +0.3% | 59,100 | +41.1% | 0.02% | +11.8% |
| Q4 2015 | $1,119,000 | +41.1% | 41,900 | +28.9% | 0.02% | +21.4% |
| Q3 2015 | $793,000 | – | 32,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |